The Role of P-type ATPases in Health and Diseases

A special issue of Biomolecules (ISSN 2218-273X). This special issue belongs to the section "Cellular Biochemistry".

Deadline for manuscript submissions: 31 August 2024 | Viewed by 1399

Special Issue Editors

Department of Pediatrics, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, CA 90073, USA
Interests: ATPase; Na,K-ATPase; glycosylation; membrane trafficking; protein folding; ion transport; membrane proteins; epithelial integrity

E-Mail Website
Guest Editor
Nemours Children's Health, Wilmington, DE, USA
Interests: cancer biology; 3D culture; drug discovery; cancer biomarkers; cell signaling; cell proliferation; signal transduction; tumor biology; neurobiology; molecular cell biology; animal models
Division of Pulmonary and Critical Care Medicine, Feinberg School of Medicine, Northwestern University, Chicago, IL 60611, USA
Interests: Na,K-ATPase; epithelial biology; FXYD5; inflammation; adhesion

Special Issue Information

Dear Colleagues,

P-type ATPases are a large group of related pumps that hydrolyze ATP to perform the active transport of ions or phospholipids across cellular membranes. All P-type ATPases form a transient phosphorylated intermediate at the key conserved aspartate residue within the pump during a catalytic cycle. The ion pumps create electrochemical gradients that are essential for transepithelial transport, nutrient uptake and the regulation of the membrane potential and cell volume. In addition, they mediate intracellular signaling and intercellular adhesion. Phospholipid flippases regulate the asymmetric lipid distribution across the lipid bilayer and are critical for the biogenesis of cell membranes and for important processes such as apoptosis and thrombus formation.

Dysfunctions of P-type ATPases are known to contribute to various diseases. Mutations in the alpha2 and alpha3 subunits of Na,K-ATPase are associated with neurological diseases, including rapid-onset dystonia–parkinsonism, and mutations in the alpha1 subunit of the Na,K-ATPase have been found to cause Charcot–Marie–Tooth type 2 disease. The malfunctioning of the Ca-ATPases contributes to hypertension and neurodegenerative diseases, and mutations in this pump can cause cardiac dysfunction, deafness, hypertension, cerebellar ataxia, heart failure, Brody myopathy and Darier disease. Mutations in the Cu-ATPases cause Menkes and Wilson diseases. Deficiencies in phospholipid flippases have been linked to progressive familial intrahepatic cholestasis, obesity, diabetes, hearing loss and neurological diseases. Recent studies have shown that the severity of disease symptoms does not always correlate with the degree of the loss of transport activity due to mutations, suggesting that misfolding during biosynthesis and following unfolded protein response significantly contribute to pathogenicity separately from the functional impairment of the pump.

For this research topic, we aim to present an update on the structure and function of P-type ATPases, with an emphasis on newly identified functions of well-characterized pumps, the emerging functions of less known P-type ATPases, novel experimental approaches to study these enzymes and the mechanisms of disease-causing genetic mutations. We encourage the submission of expert opinions, commentaries, reviews and manuscripts describing original data.

Dr. Olga Vagin
Dr. Sigrid A. Langhans
Dr. Laura Dada
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomolecules is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • P-type ATPases
  • Na,K-ATPase
  • H-ATPase
  • H,K-ATPase
  • Ca-ATPase
  • Cu-ATPase
  • phospholipid flippases
  • genetic disease

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Research

20 pages, 3113 KiB  
Article
Na+,K+-ATPase with Disrupted Na+ Binding Sites I and III Binds Na+ with Increased Affinity at Site II and Undergoes Na+-Activated Phosphorylation with ATP
by Hang N. Nielsen, Rikke Holm, Ryan Sweazey, Jens Peter Andersen, Pablo Artigas and Bente Vilsen
Biomolecules 2024, 14(1), 135; https://doi.org/10.3390/biom14010135 - 22 Jan 2024
Viewed by 939
Abstract
Na+,K+-ATPase actively extrudes three cytoplasmic Na+ ions in exchange for two extracellular K+ ions for each ATP hydrolyzed. The atomic structure with bound Na+ identifies three Na+ sites, named I, II, and III. It has [...] Read more.
Na+,K+-ATPase actively extrudes three cytoplasmic Na+ ions in exchange for two extracellular K+ ions for each ATP hydrolyzed. The atomic structure with bound Na+ identifies three Na+ sites, named I, II, and III. It has been proposed that site III is the first to be occupied and site II last, when Na+ binds from the cytoplasmic side. It is usually assumed that the occupation of all three Na+ sites is obligatory for the activation of phosphoryl transfer from ATP. To obtain more insight into the individual roles of the ion-binding sites, we have analyzed a series of seven mutants with substitution of the critical ion-binding residue Ser777, which is a shared ligand between Na+ sites I and III. Surprisingly, mutants with large and bulky substituents expected to prevent or profoundly disturb Na+ access to sites I and III retain the ability to form a phosphoenzyme from ATP, even with increased apparent Na+ affinity. This indicates that Na+ binding solely at site II is sufficient to promote phosphorylation. These mutations appear to lock the membrane sector into an E1-like configuration, allowing Na+ but not K+ to bind at site II, while the cytoplasmic sector undergoes conformational changes uncoupled from the membrane sector. Full article
(This article belongs to the Special Issue The Role of P-type ATPases in Health and Diseases)
Show Figures

Graphical abstract

Back to TopTop